Sequential combination of low dose chemo-modulating Temozolomide and Fotemustine in metastatic melanoma: clinical and molecular evaluation

被引：0
|
作者：
De Summa, S. [1 ]
Pinto, R. [1 ]
Strippoli, S. [1 ]
Natalicchio, I. [2 ]
Azzariti, A. [1 ]
Cramarossa, A. [1 ]
Signorile, M. [1 ]
Albano, A. [1 ]
Lorusso, V. [1 ]
Guida, G. [3 ]
Guida, M. [1 ]
Tommasi, S. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II Bari, Bari, Italy
[2] Az Osped Univ Osp Riuniti Foggia, Bari, Italy
[3] Univ Bari, Scuola Med, Bari, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B03
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE WITH FOTEMUSTINE IN METASTATIC MELANOMA (MM). A PHASE II STUDY
    Guida, M.
    Cramarossa, A.
    Petrillo, P.
    Albano, A.
    Pisconti, S.
    Aieta, M.
    Traversa, M.
    Ridolfi, R.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [2] High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
    Guida, Michele
    Cramarossa, Antonio
    Fistola, Ettore
    Porcelli, Mariangela
    Giudice, Giuseppe
    Lubello, Katia
    Colucci, Giuseppe
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [3] High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
    Michele Guida
    Antonio Cramarossa
    Ettore Fistola
    Mariangela Porcelli
    Giuseppe Giudice
    Katia Lubello
    Giuseppe Colucci
    [J]. Journal of Translational Medicine, 8
  • [4] HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) plus FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY
    Guida, M.
    Cramarossa, A.
    Fistola, E.
    Porcelli, M.
    Lubello, K.
    Misino, A.
    Colucci, G.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 : S104 - S104
  • [5] Temozolomide in combination with fotemustine in patients with metastatic melanoma
    Faruk Tas
    Hakan Camlica
    Erkan Topuz
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 293 - 298
  • [6] Temozolomide in combination with fotemustine in patients with metastatic melanoma
    Tas, Faruk
    Camlica, Hakan
    Topuz, Erkan
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 293 - 298
  • [7] The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
    Michele Guida
    Stefania Tommasi
    Sabino Strippoli
    Maria Iole Natalicchio
    Simona De Summa
    Rosamaria Pinto
    Antonio Cramarossa
    Anna Albano
    Salvatore Pisconti
    Michele Aieta
    Ruggiero Ridolfi
    Amalia Azzariti
    Gabriella Guida
    Vito Lorusso
    Giusepe Colucci
    [J]. BMC Cancer, 18
  • [8] The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
    Guida, Michele
    Tommasi, Stefania
    Strippoli, Sabino
    Natalicchio, Maria Iole
    De Summa, Simona
    Pinto, Rosamaria
    Cramarossa, Antonio
    Albano, Anna
    Pisconti, Salvatore
    Aieta, Michele
    Ridolfi, Ruggiero
    Azzariti, Amalia
    Guida, Gabriella
    Lorusso, Vito
    Colucci, Giusepe
    [J]. BMC CANCER, 2018, 18
  • [9] Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma
    Masucci, Giuseppe Valentino
    Mansson-Brahme, Eva
    Ragnarsson-Olding, Boel
    Nilsson, Bo
    Wagenius, Gunnar
    Hansson, Johan
    [J]. MELANOMA RESEARCH, 2006, 16 (04) : 357 - 363
  • [10] Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma
    Semb, KA
    Aamdal, S
    Bohmann, T
    Lucas, C
    Gerard, B
    [J]. MELANOMA RESEARCH, 1998, 8 (06) : 565 - 572
12345